Immucell Corp (ICCC) Reports Q2 Loss of $0.10/Share

Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of ($0.10), versus $0.01 reported last year. Revenue for the quarter came in at $1.54 million, versus $1.37 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Lennar Corp. (LEN) Misses Q3 EPS by 10c
• Hertz Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Hertz Global Holdings, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit